Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

roche.com

Investor Update

Get the latest updates from Investor Update directly as they happen.

Follow now 108 followers

Latest posts

Last updated 1 day ago

Regeneron's REGN-COV2 antibody cocktail: Prospective data from ongoing Phase 2/3 COVID-19 outpatient trial

1 day ago

Dear Investor, Please find attached a press release from our partner Regeneron:https://investor.regeneron.com/news-releases/news-release-details/regenerons-covid-19-outpatient-trial-prospectively-demonstrates...

Roche’s Tecentriq in combination with Avastin approved in China for people with the most common form of liver cancer

1 day ago

             Basel, 29 October 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today...

Roche announces full FDA approval for Venclexta combinations for acute myeloid leukaemia

12 days ago

             Basel, 19 October 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today...

Chugai Files NDA for Risdiplam as the First Oral Drug for Spinal Muscular Atrophy in Japan

15 days ago

Dear Investor, Please find attached a press release by Chugai: https://www.roche.com/201015_IR_Chugai_eRisdiplam_NDA.pdf Do...

First nine months of the year with 1% sales growth at constant exchange rates, significant impact of COVID-19 pandemic

16 days ago

Group sales increase 1% at constant exchange rates and decline 5% in...

Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients

18 days ago

Roche announced today that it intends to launch a high-volume SARS-CoV-2 Antigen...

Reminder: Invitation to Roche’s 3rd Quarter Sales 2020 Webinar

22 days ago

Roche will publish its Sales Results for the 3rd Quarter of 2020...

Regeneron's REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients

about 1 month ago

Dear Investor, Please find attached a press release from our partner Regeneron:https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and...

Roche presents new 2-year data for Evrysdi (risdiplam) in infants with Type 1 spinal muscular atrophy (SMA)

about 1 month ago

Basel, 28 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today...

Tecentriq in combination with Avastin in 1L HCC approved in Japan

about 1 month ago

Dear Investor, Please find attached a press release by Chugai: https://www.roche.com/200925_IR_eTecentriq_Avastin_HCC_approval.pdf Do...